GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Beyond Medical Technologies Inc (FRA:7FM) » Definitions » Debt-to-Equity

Beyond Medical Technologies (FRA:7FM) Debt-to-Equity : 0.00 (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Beyond Medical Technologies Debt-to-Equity?

Beyond Medical Technologies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was €0.00 Mil. Beyond Medical Technologies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was €0.00 Mil. Beyond Medical Technologies's Total Stockholders Equity for the quarter that ended in Sep. 2023 was €-0.06 Mil. Beyond Medical Technologies's debt to equity for the quarter that ended in Sep. 2023 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Beyond Medical Technologies's Debt-to-Equity or its related term are showing as below:

During the past 13 years, the highest Debt-to-Equity Ratio of Beyond Medical Technologies was 0.11. The lowest was 0.03. And the median was 0.04.

FRA:7FM's Debt-to-Equity is not ranked *
in the Industrial Products industry.
Industry Median: 0.29
* Ranked among companies with meaningful Debt-to-Equity only.

Beyond Medical Technologies Debt-to-Equity Historical Data

The historical data trend for Beyond Medical Technologies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beyond Medical Technologies Debt-to-Equity Chart

Beyond Medical Technologies Annual Data
Trend Jul13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.07 0.11 0.06 -

Beyond Medical Technologies Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 - - - -

Competitive Comparison of Beyond Medical Technologies's Debt-to-Equity

For the Pollution & Treatment Controls subindustry, Beyond Medical Technologies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beyond Medical Technologies's Debt-to-Equity Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Beyond Medical Technologies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Beyond Medical Technologies's Debt-to-Equity falls into.



Beyond Medical Technologies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Beyond Medical Technologies's Debt to Equity Ratio for the fiscal year that ended in Dec. 2022 is calculated as

Beyond Medical Technologies's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Beyond Medical Technologies  (FRA:7FM) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Beyond Medical Technologies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Beyond Medical Technologies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Beyond Medical Technologies (FRA:7FM) Business Description

Traded in Other Exchanges
Address
1055 West Georgia Street, Suite 1500, Vancouver, BC, CAN, V6H 1C3
Beyond Medical Technologies Inc is seeking to find new opportunities.

Beyond Medical Technologies (FRA:7FM) Headlines

No Headlines